Atnaujinkite slapukų nuostatas

Clinical Manifestations and Assessment of Respiratory Disease 9th edition [Minkštas viršelis]

4.26/5 (38 ratings by Goodreads)
(Associate Dean for Medical Affairs, Kettering College of Medical Arts, Kettering, Ohio; Clinical Professor of Medicine and Anes), (Director, Professor Emeritus, Department of Respiratory Care, Parkland College, Champaign, Illinois, USA)
  • Formatas: Paperback / softback, 672 pages, aukštis x plotis: 276x216 mm, weight: 1450 g
  • Išleidimo metai: 16-Jun-2023
  • Leidėjas: Mosby
  • ISBN-10: 032387150X
  • ISBN-13: 9780323871501
Kitos knygos pagal šią temą:
Clinical Manifestations and Assessment of Respiratory Disease 9th editionDidesnis paveikslėlis
  • Formatas: Paperback / softback, 672 pages, aukštis x plotis: 276x216 mm, weight: 1450 g
  • Išleidimo metai: 16-Jun-2023
  • Leidėjas: Mosby
  • ISBN-10: 032387150X
  • ISBN-13: 9780323871501
Kitos knygos pagal šią temą:
Pastovi nuoroda: https://www.kriso.lt/db/9780323871501.html
Raktažodžiai:

A realistic look at treating respiratory diseases! Clinical Manifestations and Assessment of Respiratory Disease, 9th Edition gives you the fundamental knowledge and understanding required to successfully assess and treat patients with respiratory diseases. This foundation helps you learn how to systematically gather relevant clinical data; make an objective evaluation; identify the desired outcome and formulate an assessment; design a safe, appropriate, and effective treatment plan; and document all the steps involved. With this knowledge, you will understand the effectiveness of performing therapies and when to adjust therapy to a desired outcome.

  • UNIQUE! Emphasis on clinical scenarios and critical thinking skills
  • prepares you for real-world practice.
  • UNIQUE! Focus on assessment and Therapist Driven Protocols (TDPs).
  • UNIQUE! Overview boxes highlight the clinical manifestations for each disease.
  • Logically organized content is written at a user-friendly, approachable reading level for ease of use and understanding.
  • Case studies provide realistic examples of the respiratory therapy practitioner’s role in successful patient care.
  • End-of-chapter self-assessment questions and answer key are available on the companion Evolve website.
  • NEW! Clinical Connection boxes
  • provide real-world clinical case studies in relevant chapters.
  • NEW! An updated design and additional tables, boxes, and figures draw attention to key information.
  • UPDATED! Content includes the latest developments related to SARS and COVID-19.
  • UPDATED! Information on ventilators, usage, and protocols reflects current practice.
  • NEW! QR codes in most chapters direct to additional outside content to enhance the chapter, including audio sounds and animations.
PART I ASSESSMENT OF CARDIOPULMONARY DISEASE
1(1)
SECTION 1 Bedside Diagnosis
1(53)
1 The Patient Interview
1(10)
Patient History
1(1)
The Patient Interview
1(3)
Techniques of Communication
4(4)
Closing the Interview
8(1)
Pitfalls and Weaknesses Associated With the Patient Interview
8(2)
A Note of Reassurance
10(1)
2 The Physical Examination
11(19)
Vital Signs
12(8)
Systematic Examination of the Chest and Lungs
20(10)
3 The Pathophysiologic Basis for Common Clinical Manifestations
30(24)
The Normal Respiratory System--Basic Review
31(1)
Dysanapsis--Irregularity of Airway Size, Shape, and Distribution
32(3)
Normal Ventilatory Pattern
35(1)
Abnormal Ventilatory Patterns
35(7)
The Onset/Offset Patterns Associated With Various Cardiopulmonary Disorders
42(1)
Use of the Accessory Muscles of Inspiration
43(1)
Use of the Accessory Muscles of Expiration
44(2)
Nasal Flaring
46(1)
Splinting and Decreased Chest Expansion Caused by Pleuritic and Nonpleuritic Chest Pain
46(1)
Abnormal Chest Shape and Configuration
47(1)
Abnormal Extremity Findings
47(3)
Distended Neck Veins and Jugular Venous Distention
50(1)
Cough
50(4)
SECTION 2 Clinical Data Obtained From Laboratory Tests and Special Procedures--Objective Findings
54(83)
4 Pulmonary Function Testing
54(16)
Normal Lung Volumes and Capacities
55(2)
Common Pulmonary Function Test Findings in Respiratory Disease
57(1)
Forced Expiratory Flow Rate and Volume Measurements
58(7)
Pulmonary Diffusion Capacity
65(1)
Assessment of Respiratory Muscle Strength
66(1)
Cardiopulmonary Exercise Testing
66(1)
Other Diagnostic Tests for Asthma
67(3)
5 Blood Gas Assessment
70(13)
Acid-Base Abnormalities
70(11)
Errors Associated With Arterial Blood Gas Measurements
81(2)
6 Assessment of Oxygenation
83(14)
The Role and Importance of Oxygen
83(1)
Oxygen Transport Review
84(1)
Total Oxygen Content of Blood
85(1)
Oxyhemoglobin Dissociation Curve
86(1)
Oxygenation Indices
86(7)
Hypoxemia Versus Hypoxia
93(4)
7 Assessment of the Cardiovascular System
97(12)
The Electrocardiogram
97(1)
Common Heart Arrhythmias
98(3)
Noninvasive Hemodynamic Monitoring Assessments
101(2)
Invasive Cardiovascular Monitoring Assessments
103(1)
Cardiovascular (Hemodynamic) Monitoring in Respiratory Diseases
104(5)
8 Radiologic Examination of the Chest
109(15)
Fundamentals of Radiography
109(1)
Standard Positions and Techniques of Chest Radiography
110(2)
Inspecting the Chest Radiograph
112(11)
Radiation Safety
123(1)
9 Diagnostic Tests and Procedures
124(13)
Sputum Examination
124(1)
Skin Tests
125(1)
Endoscopic Examinations
125(3)
Video-Assisted Thoracoscopy Surgery
128(1)
Thoracentesis
129(1)
Pleurodesis
130(1)
Hematology, Blood Chemistry, and Electrolyte Findings
130(7)
SECTION 3 The Therapist-Driven Protocol Program--The Essentials
137(55)
10 The Therapist-Driven Protocol Program
137(23)
The Purpose of Respiratory Therapist-Driven Protocols
138(1)
The "Knowledge Base" Required for a Successful Therapist-Driven Protocol Program
139(1)
The "Assessment Process Skills" Required for a Successful Therapist-Driven Protocol Program
139(3)
The Essential Cornerstones of a Successful Therapist-Driven Protocol Program
142(8)
Common Anatomic Alterations of the Lungs
150(10)
11 Respiratory Failure and Ventilatory Management Protocols
160(24)
Classifications of Respiratory Failure
161(6)
Mechanical Ventilation
167(11)
Ventilator Hazards
178(4)
Extracorporeal Membrane Oxygenation
182(2)
12 Recording Skills and Intraprofessional Communication
184(8)
Types of Patient Records
184(6)
Telemedicine
190(1)
Health Insurance Portability and Accountability Act
190(2)
PART II OBSTRUCTIVE LUNG DISEASE
192(90)
13 Chronic Obstructive Pulmonary Disease, Chronic Bronchitis, and Emphysema
192(30)
Anatomic Alterations of the Lungs Associated With Chronic Bronchitis
193(1)
Anatomic Alterations of the Lungs Associated With Emphysema
193(1)
Etiology and Epidemiology
194(1)
Risk Factors
195(1)
Diagnosis and Assessment of Chronic Obstructive Pulmonary Disease
196(4)
Key Distinguishing Features Between Emphysema and Chronic Bronchitis
200(8)
General Management of Chronic Obstructive Pulmonary Disease
208(1)
Management of Stable Chronic Obstructive Pulmonary Disease
208(6)
Management of Acute Chronic Obstructive Pulmonary Disease Exacerbations
214(2)
Case Study 1 Chronic Bronchitis
216(2)
Case Study 2 Emphysema
218(2)
Case Study 3 Example of Classic Chronic Obstructive Pulmonary Disease
220(2)
14 Asthma
222(30)
National Asthma Education and Prevention Program
223(1)
Global Initiative for Asthm
223(1)
Anatomic Alterations of the Lungs
223(2)
Etiology and Epidemiology
225(3)
Diagnosis of Asthma
228(5)
General Management of Asthma
233(15)
Respiratory Care Treatment Protocols
248(1)
Case Study: Asthma (Pediatric Asthma)
249(3)
15 Cystic Fibrosis
252(17)
Anatomic Alterations of the Lungs
252(1)
Etiology and Epidemiology
253(7)
General Management of Cystic Fibrosis
260(4)
Lung or Heart-Lung Transplantation
264(1)
Case Study: Cystic Fibrosis
265(4)
16 Bronchiectasis
269(13)
Anatomic Alterations of the Lungs
269(1)
Etiology and Epidemiology
270(1)
Diagnosis
271(8)
General Management of Bronchiectasis
279(1)
Medications Commonly Prescribed by the Physician
279(1)
Case Study: Bronchiectasis
280(2)
PART III LOSS OF ALVEOLAR VOLUME
282(5)
17 Atelectasis
282(5)
Anatomic Alterations of the Lungs
282(1)
Etiology
282(3)
General Management of Postoperative Atelectasis
285(1)
Case Study: Postoperative Atelectasis
286(1)
PART IV INFECTIOUS PULMONARY DISEASE
287(37)
18 Pneumonia, Lung Abscess Formation, and Important Fungal Diseases
287(25)
Pneumonia: Anatomic Alterations of the Lungs
288(1)
Etiology and Epidemiology
288(4)
Community-Acquired Typical Pneumonia
292(1)
Community-Acquired Atypical Pneumonia
293(4)
Chronic Pneumonia
297(1)
Fungal Diseases: Anatomic Alterations of the Lungs
297(1)
Primary Pathogens
298(2)
Pneumonia in the Immunocompromised Host
300(5)
Necrotizing Pneumonia and Lung Abscess
305(4)
General Management of Pneumonia
309(1)
Case Study: Pneumonia
310(2)
19 Tuberculosis
312(12)
Primary TB
312(1)
Latent TB
313(1)
Reactivation TB
313(1)
Disseminated TB
313(1)
Anatomic Alterations of the Lungs
314(1)
Etiology and Epidemiology
314(1)
Diagnosis
315(2)
Atypical Mycobacterial Infection
317(3)
General Management of Tuberculosis
320(2)
Case Study: Tuberculosis
322(2)
PART V PULMONARY VASCULAR DISEASE
324(27)
20 Pulmonary Edema
324(9)
Anatomic Alterations of the Lungs
324(1)
Etiology and Epidemiology
325(5)
General Management of Pulmonary Edema
330(1)
Case Study: Pulmonary Edema
331(2)
21 Pulmonary Vascular Disease: Pulmonary Embolism and Pulmonary Hypertension
333(18)
Pulmonary Embolism
334(1)
Diagnosis and Screening
335(6)
General Management of Pulmonary Embolism
341(2)
Pulmonary Hypertension
343(1)
The Emerging Role of the Respiratory Therapist in Pulmonary Vascular Disorders
344(4)
Case Study: Pulmonary Embolism
348(3)
PART VI CHEST AND PLEURAL TRAUMA
351(15)
22 Flail Chest
351(6)
Anatomic Alterations of the Lungs
351(1)
Etiology and Epidemiology
351(3)
General Management of Flail Chest
354(1)
Case Study: Flail Chest
355(2)
23 Pneumothorax
357(9)
Anatomic Alterations of the Lungs
357(1)
Etiology, Epidemiology, and Symptoms
357(6)
General Management of Pneumothorax
363(1)
Case Study: Spontaneous Pneumothorax
364(2)
PART VII DISORDERS OF THE PLEURA AND THE CHEST WALL
366(20)
24 Pleural Effusion and Empyema
366(9)
Anatomic Alterations of the Lungs
366(1)
Pleural Anatomy and Pathophysiology
366(1)
Etiology and Epidemiology
367(4)
General Management of Pleural Effusion
371(1)
Case Study: Pleural Disease
372(3)
25 Kyphoscoliosis
375(11)
Anatomic Alterations of the Lungs
375(1)
Etiology and Epidemiology
375(1)
Scoliosis
375(1)
Kyphosis
376(3)
General Management of Scoliosis
379(3)
Case Study: Kyphoscoliosis
382(4)
PART VIII LUNG CANCER
386(22)
26 Cancer of the Lung
386(22)
Anatomic Alterations of the Lungs
386(1)
Etiology and Epidemiology
387(3)
Screening and Diagnosis
390(11)
General Management of Lung Cancer
401(3)
Case Study: Cancer of the Lung
404(4)
PART IX ENVIRONMENTAL LUNG DISEASES
408(17)
27 Interstitial Lung Diseases
408(17)
Anatomic Alterations of the Lungs
408(1)
Etiology and Epidemiology
409(11)
General Management of Interstitial Lung Disease
420(1)
Case Study: Interstitial Lung Disease
421(4)
PART X DIFFUSE ALVEOLAR DISEASE
425(13)
28 Acute Respiratory Distress Syndrome
425(13)
Anatomic Alterations of the Lungs
425(1)
Etiology and Epidemiology
425(2)
Diagnostic Criteria for Acute Respiratory Distress Syndrome
427(2)
General Management of Acute Respiratory Distress Syndrome
429(4)
Respiratory Management Protocol for Patients With Severe SARS-CoV-2 (COVID-19) and ARDS Using the SpO2/FlO2 Ratio, PaO2/FlO2 Ratio, and SpO2
433(3)
Case Study: Acute Respiratory Distress Syndrome
436(2)
PART XI NEURO-RESPIRATORY DISORDERS
438(33)
29 Guillain-Barre Syndrome
438(7)
Anatomic Alterations of the Lungs Associated With Guillain-Barre Syndrome
438(1)
Etiology and Epidemiology
438(1)
Clinical Presentation
439(2)
General Management of Guillain-Barre Syndrome
441(2)
Case Study: Guillain-Barre Syndrome
443(2)
30 Myasthenia Gravis
445(9)
Anatomic Alterations of the Lungs Associated With Myasthenia Gravis
445(1)
Etiology and Epidemiology
446(1)
Screening and Diagnosis
446(3)
General Management of Myasthenia Gravis
449(2)
Case Study: Myasthenia Gravis
451(3)
31 Cardiopulmonary Assessment and Care of Patients with Neuromuscular Disease
454(17)
Chronic Neuromuscular Diseases
454(11)
General Management of Neuromuscular Disease
465(1)
Ventilatory Management of Patients with Neuromuscular Disease
465(2)
Case Study: Amyotrophic Lateral Sclerosis
467(4)
PART XII SLEEP-RELATED BREATHING DISORDERS
471(19)
32 Sleep Apnea
471(19)
Obstructive Sleep Apnea
472(1)
Central Sleep Apnea
473(1)
Mixed Apnea
474(1)
Sleep-Related Hypoventilation and Hypoxemia Syndromes
475(1)
Diagnosis of Obstructive Sleep Apnea
475(8)
General Management of Obstructive Sleep Apnea
483(2)
General Management of Central Sleep Apnea
485(2)
Case Study: Obstructive Sleep Apnea
487(3)
PART XIII NEWBORN AND EARLY CHILDHOOD CARDIOPULMONARY DISORDERS
490(115)
33 Newborn Assessment and Management
490(25)
Fetal Development and Transition at Birth
491(4)
Delivery Room Management of the Newborn
495(5)
Assessment of the Newborn
500(4)
Special Newborn Conditions and Topics
504(11)
34 Pediatric Assessment and Management
515(18)
Special Challenges in Pediatric Care
515(1)
Common Infant and Pediatric Cardiopulmonary Disorders
516(1)
Assessment of the Infant and Pediatric Patient
516(5)
Pediatric Treatment Protocols
521(12)
35 Meconium Aspiration Syndrome
533(7)
Anatomic Alterations of the Lungs
533(1)
Etiology and Epidemiology
534(2)
General Management of Meconium Aspiration Syndrome
536(1)
Case Study: Meconium Aspiration Syndrome
537(3)
36 Transient Tachypnea of the Newborn
540(5)
Anatomic Alterations of the Lungs
540(1)
Etiology and Epidemiology
540(3)
General Management of Transient Tachypnea of the Newborn
543(1)
Case Study: Transient Tachypnea of the Newborn
543(2)
37 Respiratory Distress Syndrome
545(7)
Anatomic Alterations of the Lungs
545(1)
Etiology and Epidemiology
546(1)
Diagnosis
546(2)
General Management of Respiratory Distress Syndrome
548(2)
Case Study: Respiratory Distress Syndrome
550(2)
38 Pulmonary Air Leak Syndromes
552(8)
Anatomic Alterations of the Lungs
553(2)
Etiology and Epidemiology
555(2)
General Management of Pulmonary Air Leak Syndromes
557(1)
Case Study: Pulmonary Air Leak Syndromes
558(2)
39 Respiratory Syncytial Virus Infection (Bronchiolitis)
560(9)
Anatomic Alterations of the Lungs
560(1)
Etiology and Epidemiology
560(4)
General Management of Respiratory Syncytial Virus Infection (Bronchiolitis)
564(2)
Case Study: Respiratory Syncytial Virus Infection (Bronchiolitis)
566(3)
40 Bronchopulmonary Dysplasia
569(9)
Anatomic Alterations of the Lungs
569(2)
Etiology and Epidemiology
571(2)
General Management of Bronchopulmonary Dysplasia
573(3)
Case Study: Bronchopulmonary Dysplasia
576(2)
41 Congenital Diaphragmatic Hernia
578(5)
Anatomic Alterations of the Lungs
578(1)
Etiology and Epidemiology
579(1)
General Management of a Congenital Diaphragmatic Hernia
580(1)
Case Study: Diaphragmatic Hernia
581(2)
42 Congenital Heart Diseases
583(12)
Patent Ductus Arteriosus
584(2)
Atrial Septal Defect
586(1)
Ventricular Septal Defect
587(2)
Tetralogy of Fallot
589(2)
Transposition of the Gceat Arteries
591(1)
Hypoplastic Left Heart Syndrome
592(1)
Case Study: Transposition of the Great Arteries
593(2)
43 Croup and Croup-Like Syndromes: Laryngotracheobronchitis, Bacterial Tracheitis, and Acute Epiglottitis
595(10)
Anatomic Alterations of the Upper Airway
595(1)
Etiology and Epidemiology
596(5)
General Management of Laryngotracheobronchitis, Bacterial Tracheitis, and Epiglottitis
601(1)
Case Study 1 Laryngotracheobronchitis
602(1)
Case Study 2 Acute Epiglottitis
603(1)
Case Study 3 Bacterial Tracheitis
604(1)
PART XIV OTHER IMPORTANT TOPICS
605(16)
44 Near Drowning/Wet Drowning
605(6)
Anatomic Alterations of the Lungs
605(1)
Etiology and Epidemiology
605(3)
General Management of Near Drowning and Wet Drowning
608(1)
Case Study: Near Wet Drowning
609(2)
45 Smoke Inhalation, Thermal Lung Injuries, and Carbon Monoxide Intoxication
611(10)
Anatomic Alterations of the Lungs
611(2)
Etiology and Epidemiology
613(1)
Body Surface Burns
614(3)
General Management of Smoke Inhalation and Thermal Injuries
617(2)
Case Study: Smoke Inhalation and Thermal Injury
619(2)
Index 621